Login to Your Account

U.S. Patent Disclosures

Thursday, March 1, 2012
• Immunomedics Inc., of Morris Plains, N.J., was granted U.S. Patent No. 8,105,596, titled "Immunotherapy of B-cell malignancies using anti-CD22 antibodies." It covers therapeutic compositions comprising any combination of conjugated or unconjugated anti-CD20 and anti-CD22 antibodies.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription